Skip to content
FDAMedicines

BD Announces Voluntary Worldwide Recall for One Lot of ChloraPrep™ Clear 1 mL Applicators Due to Fungal Contamination

FDA recall n-bd-announces-voluntary-worldwide-recall-one-lot-chlorapreptm-clear-1-ml-applicat ·

Build snapshot. Collected , once, when this site was built. It is not a live feed.

Check my lot or code

Is yours in this recall?

Type the lot, batch, date code, model number or UPC printed on the product. It is compared here, in your browser, with the codes this notice lists. It stays in this page: it is not added to the address.

General information on recalls from the agency: U.S. Food and Drug Administration (opens in a new tab).

What the agency says to do

FDA’s record gives no instruction for consumers.

Note from Recalls Watch, not agency text

Why it was recalled

Potential for fungal contamination under certain environmental conditions allowing the growth of Aspergillus penicillioides
Text from FDA, unedited.

The recalled product

BD (Becton, Dickinson and Company) today announced the voluntary recall of one lot of ChloraPrep™ Clear 1 mL Applicators due to fungal contamination under certain environmental conditions allowing the growth of Aspergillus penicillioides
Text from FDA, unedited.

Company announcement, as FDA publishes it

FRANKLIN LAKES, N.J. (Feb. 15, 2025) – BD (Becton, Dickinson and Company) today announced the voluntary recall of one lot of ChloraPrep™ Clear 1 mL Applicators due to fungal contamination under certain environmental conditions allowing the growth of Aspergillus penicillioides.

The Aspergillus penicillioides within the packaging can contaminate the surface of the applicator and/or gloved hands of the health care professional and then consequently the sterile field. Since the applicator is used for site preparation prior to an invasive procedure, a contaminated applicator can result in direct inoculation of the fungus into tissues. This lot was distributed globally beginning in September 2023. To date, there have been no reported customer complaints or adverse events associated with this issue.

Risk Statement: Contamination of skin preparation products with Aspergillus penicillioides may lead to serious systemic infection, sepsis, illness, and death. If the fungus is introduced in the patient’s bloodstream during placement of an intravascular catheter, the catheter would most likely have to be removed, necessitating another procedure. Aspergillus penicillioides infection of a surgical site may result in the need for medical and surgical interventions and long-term treatment with antifungal drugs.

The product is used for the preparation of the patient’s skin prior to surgery, helps to reduce bacteria that potentially can cause skin infection, and is packaged in a pouch (1 applicator per pouch, 60 applicators per inner carton).

The affected lot (3200240) can be identified by locating the above referenced catalog and lot number on the lidding of the product package and the side of the individual shelf box and shipper box. Please immediately discontinue use of the affected lot. Check all inventory locations within your facility and destroy all affected units in accordance with your facility’s process. If destruction is not immediately possible at your facility, then product should be quarantined until disposal.

This recall should be carried out to the Distributor, Hospital and User levels. BD is instructing distributors to identify all customers within their distribution network who may have purchased any of the affected product listed.

Customer inquiries related to this recall, as well as adverse reaction/events experienced with the product, should be addressed to BD’s Complaint Center: 1-844-823-5433 (Toll Free) Monday – Friday between the hours of 9 a.m. and 6 p.m. ET or by emailing: productcomplaints@bd.com .

The U.S. Food and Drug Administration (FDA) has been notified of this recall.

FDA MedWatch Reporting

Adverse reactions/events experienced with the use of any of these products should also be reported to the FDA's MedWatch Adverse Event Reporting program either online, phone or by regular mail.

Complete and submit the report Online: www.fda.gov/medwatch/report.htm

Call 1-800-FDA-1088 (1-800-332-1088) • Regular Mail: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form or submit by fax to 1-800-FDA-0178.

About BD

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ , X (formerly Twitter) @BDandCo or Instagram @becton_dickinson .

Media: Investors: Troy Kirkpatrick Adam Reiffe BD Public Relations BD Investor Relations 858.617.2361 201.847.6927 Troy.Kirkpatrick@bd.com adam.reiffe@bd.com

Text from FDA (the company’s words), unedited.
  • BD ChloraPrep™ Clear - 1 mL Applicator 60 Applicators per Inner Carton 4 Inner Cartons per Case

    Lot or code
    Affected Product NDC: 54365-400-31; Catalog (REF) Number: 930480; Lot Number: 3200240; Expiry Date: 6/30/2026

Source

Issued by
U.S. Food and Drug Administration
Firm
BD

Check all notices that name this firm in the directory of recalls by brand and manufacturer. This notice is in these lists: Firm: BD, Month: February 2025, Week 2025-W07. Browse more medicines recalls, or check another notice by its number in the recall number lookup.

About this recall

What is the hazard?

FDA states: “Potential for fungal contamination under certain environmental conditions allowing the growth of Aspergillus penicillioides”

What should I do if I have this product?

FDA’s record gives no instruction for consumers. The official report is linked on this page.

How do I know if my product is included?

Compare the lot or code printed on your product with the codes FDA lists on this notice, product by product.

How does the code check on this page work?

You type the lot, batch, date code, model number or UPC from your package and the page compares it, in your browser, with the codes FDA lists on this notice. It reports a match, a possible match (your code is part of a longer listed code) or no match. It only compares text: a notice that describes products by dates, sizes or “all lots” cannot be compared, so “no match” does not clear a product. The comparison runs in your browser and the page does not send the code anywhere, and the code stays out of the page address. Only if you press “Copy link to this result” is a link made that carries it, and whoever opens that link requests that address from this site.

When was this recall published?

FDA published this company announcement on February 15, 2025.

Other notices of BD